Skip to main content

Table 5 Significant covariates with respect to the survival and related log-rank test P-Values

From: Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy

Covariate p-Value HR 95%CI
Total Dose 0.01 0.08 0.01–0.63
Localization of tumour 0.04 0.26 0.06–1.10
PV thrombosis <0.001 3.51 2.01–6.13
AJCC Stage 0.001 1.42 1.10–3.01
BCLC Stage <0.001 1.38 0.95–2.84
Child Class 0.04 1.63 1.02–2.61
AFP initial level <0.001 0.39 0.25–0.63
Tumour volume <0.001 0.25 0.16–0.40
Age 0.006 2.02 1.20–3.39
Entropy (Histogram) 0.02 1.70 1.09–2.67
Compacity <0.001 0.22 0.14–0.36
Contrast 0.01 2.11 1.14–4.12
Entropy 0.04 1.61 1.03–2.88
Dissimilarity 0.01 2.17 1.14–4.12
HGRE 0.02 1.80 1.07–3.01
SRHGE 0.02 1.69 1.06–2.67
LRHGE 0.04 1.71 1.02–2.88
GLNU <0.001 0.23 0.13–0.39
RLNU <0.001 0.25 0.16–0.40
HGZE 0.02 1.83 1.09–3.07
SZHGE 0.01 1.80 1.12–2.87
GLNU <0.001 0.25 0.15–0.39
  1. Continuous numerical covariates have been split into two categories for calculating statistical test